glucose-6-phosphatase inhibitors (Novo Nordisk)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameglucose-6-phosphatase inhibitors (Novo Nordisk)
Drug Alias NameG-6-Pase inhibitors (Novo Nordisk)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose-6-phosphatase inhibitors
TargetsGlucose-6-phosphatase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A